Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms

doi:10.3748/wjg.15.2190

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5683)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-12) series.

Item

Count

PDF

464

HTML

4646

Figures (1-4)

289

Tables (1-12)

284

Sum=5683

May 14, 2009 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlights

World J Gastroenterol. May 14, 2009; 15(18): 2190-2203
Published online May 14, 2009. doi: 10.3748/wjg.15.2190

Full Size Figure Download Figure

Figure 1 The SAFE-biopsy algorithm for significant fibrosis (≥ F2 by METAVIR). The figure reports the cut-offs used for APRI and Fibrotest in the decisional tree.

Citation: Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203
URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2190.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2190